The Data and Safety Monitoring Committee ( DSMC ) recommended stopping the trial on Jan 6 , 2011 ( last patient visit July , 2011 ) , after an interim analysis , and suggested a change in primary outcome from the difference in proportions of patients with incident progression between groups to time to visual field deterioration within 24 months .